Table of Content

1 Markets
1.1 Product Definition
1.2 Inclusion and Exclusion Criteria
1.3 Market Scope
1.3.1 Scope of the Study
1.3.2 Key Questions Answered in the Report
1.4 Research Methodology
1.4.1 Global Functional Genomics Market: Research Methodology
1.4.2 Data Sources
1.4.3 Market Estimation Model
1.4.4 Criteria for Company Profiling

2 Market Overview
2.1 Functional Genomics Workflow Analysis
2.2 Future Potential
2.3 Impact of Functional Genomics
2.3.1 Gene Therapy
2.3.2 Drug Discovery and Development
2.3.3 Gene Expression
2.3.4 Single-Cell Analysis

3 Industry Insight
3.1 Legal and Regulatory Framework of Genetic Tests
3.1.1 Diagnostic Test
3.2 Reimbursement Scenario

4 Market Dynamics
4.1 Overview
4.2 Market Drivers
4.2.1 Integration of Multi-omics Approaches for Patient Stratification
4.2.2 Increasing Popularity of Epigenetics Leading to Vast Usage
4.2.3 Increased Technological Advancements and Government Initiatives in the Functional Genomics Ecosystem
4.3 Market Challenges
4.3.1 Limitations in Implementation of Data in Proteomics and Metabolomics
4.3.2 Regulatory Compliance Issues Related to Functional Genomics Technology
4.4 Market Opportunities
4.4.1 Upsurge in Proteomic Approaches in Biomarker Discovery
4.4.2 Rising Opportunities for Translational and Clinical Studies

5 Competitive Insight
5.1 Overview
5.2 Key Strategies and Developments
5.2.1 Synergistic Activities
5.2.2 Product Launches and Product Approvals
5.2.3 Expansions
5.2.4 Mergers and Acquisitions
5.2.5 Investments and Other Activities
5.3 Market Share Analysis (2022)

6 Global Functional Genomics Market (By Product), 2022-2033
6.1 Overview
6.1.1 Kits and Assays
6.1.2 Instruments

7 Global Functional Genomics Market (By Technology), 2022-2033
7.1 Overview
7.1.1 Next-Generation Sequencing (NGS)
7.1.2 Polymerase Chain Reaction (PCR)
7.1.3 Microarray
7.1.4 Other Technologies

8 Global Functional Genomics Market (by Application), 2022-2033
8.1 Overview
8.2 Epigenomics
8.3 Transcriptomics
8.4 Proteomics
8.5 Metabolomics

9 Global Functional Genomics Market (by End User), 2022-2033
9.1 Overview
9.2 Academic and Research Institutions
9.3 Biotechnology and Biopharmaceutical Companies
9.4 Other End Users (Hospitals, Clinics, and Diagnostic Labs)

10 Global Functional Genomics Market (By Region), 2022-2033
10.1 Overview
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest-of-Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Singapore
10.4.6 Rest-of-Asia-Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest-of-Latin America
10.6 Rest-of-the-World

11 Company Profiles
11.1 Overview
11.2 Agilent Technologies, Inc.
11.2.1 Company Overview
11.2.2 Role of Agilent Technologies, Inc. in the Global Functional Genomics Market
11.2.3 Financials
11.2.4 Key Insights about the Financial Health of the Company
11.2.5 Recent Developments
11.2.6 Analyst Perspective
11.3 Becton, Dickinson and Company (BD)
11.3.1 Company Overview
11.3.2 Role of Becton, Dickinson and Company (BD) in the Global Functional Genomics Market
11.3.3 Financials
11.3.4 Key Insights about the Financial Health of the Company
11.3.5 Analyst Perspective
11.4 Bio-Rad Laboratories, Inc.
11.4.1 Company Overview
11.4.2 Role of Bio-Rad Laboratories, Inc. in the Global Functional Genomics Market
11.4.3 Financials
11.4.4 Key Insights about the Financial Health of the Company
11.4.5 Recent Developments
11.4.6 Analyst Perspective
11.5 Danaher. (Integrated DNA Technologies, Inc.)
11.5.1 Company Overview
11.5.2 Role of Danaher. (Integrated DNA Technologies, Inc.) in the Global Functional Genomics Market
11.5.3 Financials
11.5.4 Key Insights about the Financial Health of the Company
11.5.5 Analyst Perspective
11.6 Exact Sciences Corporation
11.6.1 Company Overview
11.6.2 Role of Exact Sciences Corporation in the Global Functional Genomics Market
11.6.3 Financials
11.6.4 Key Insights about the Financial Health of the Company
11.6.5 Recent Developments
11.6.6 Analyst Perspective
11.7 F. Hoffmann-La Roche Ltd
11.7.1 Company Overview
11.7.2 Role of F. Hoffmann-La Roche Ltd in the Global Functional Genomics Market
11.7.3 Financials
11.7.4 Key Insights about the Financial Health of the Company
11.7.5 Recent Developments
11.7.6 Analyst Perspective
11.8 Illumina, Inc.
11.8.1 Company Overview
11.8.2 Role of Illumina, Inc. in the Global Functional Genomics Market
11.8.3 Financials
11.8.4 Key Insights about the Financial Health of the Company
11.8.5 Recent Developments
11.8.6 Analyst Perspective
11.9 Merck KGaA
11.9.1 Company Overview
11.9.2 Role of Merck KGaA in the Global Functional Genomics Market
11.9.3 Financials
11.9.4 Key Insights about the Financial Health of the Company
11.9.5 Analyst Perspective
11.1 MRM Proteomics
11.10.1 Company Overview
11.10.2 Role of MRM Proteomics in the Global Functional Genomics Market
11.10.3 Analyst Perspective
11.11 Pacific Biosciences of California, Inc.
11.11.1 Company Overview
11.11.2 Role of Pacific Biosciences of California, Inc. in the Global Functional Genomics Market
11.11.3 Financials
11.11.4 Key Insights about the Financial Health of the Company
11.11.5 Recent Developments
11.11.6 Analyst Perspective
11.12 Perkin Elmer, Inc.
11.12.1 Company Overview
11.12.2 Role of PerkinElmer, Inc. in the Global Functional Genomics Market
11.12.3 Financials
11.12.4 Key Insights about the Financial Health of the Company
11.12.5 Analyst Perspective
11.13 Promega Corporation
11.13.1 Company Overview
11.13.2 Role of Promega Corporation in the Global Functional Genomics Market
11.13.3 Analyst Perspective
11.14 QIAGEN
11.14.1 Company Overview
11.14.2 Role of QIAGEN in the Global Functional Genomics Market
11.14.3 Financials
11.14.4 Key Insights about the Financial Health of the Company
11.14.5 Recent Developments
11.14.6 Analyst Perspective
11.15 Thermo Fisher Scientific Inc.
11.15.1 Company Overview
11.15.2 Role of Thermo Fisher Scientific Inc. in the Global Functional Genomics Market
11.15.3 Financials
11.15.4 Key Insights about the Financial Health of the Company
11.15.5 Recent Developments
11.15.6 Analyst Perspective
List of Figures
Figure 1: Global Functional Genomics Market, $Billion, 2023 and 2033
Figure 2: Biological Features of Functional Genomics Approaches
Figure 3: Share of Global Functional Genomics Market (By Product), $Billion, 2022 and 2033
Figure 4: Share of Global Functional Genomics Market (by Application), $Billion, 2022 and 2033
Figure 5: Share of Global Functional Genomics Market (by Region), 2022
Figure 6: Global Functional Genomics Market Segmentation
Figure 7: Global Functional Genomics Market: Research Methodology
Figure 8: Primary Research Methodology
Figure 9: Bottom-Up Approach (Segment-Wise Analysis)
Figure 10: Top-Down Approach (Segment-Wise Analysis)
Figure 11: Epigenomics Workflow
Figure 12: Transcriptomics Workflow
Figure 13: Proteomics Workflow
Figure 14: Metabolomics Workflow
Figure 15: U.S. Federal Agencies and their Role in Genetic Tests
Figure 16: U.S. FDA Regulatory Workflow for Diagnostic Tests
Figure 17: Global Functional Genomics Market Dynamics
Figure 18: Rate of Adoption of Multi-omics Approach for Patient Stratification and Research
Figure 19: Total Number of Publications Published Each Year for Cancer Research Through Multi-omics
Figure 20: Total Epigenetics Publications to Understand the Development of Age-Related Chronic Diseases
Figure 21: Total Number of Clinical Trials under Drug Development for Genomics, 2016-2022
Figure 22: Share of Key Developments and Strategies, January 2020-March 2023
Figure 23: Share of Synergistic Activities (by Company), January 2020-March 2023
Figure 24: Share of Product Launches and Product Approvals (by Company), January 2020-March 2023
Figure 25: Share of Expansions (by Company), January 2020-March 2023
Figure 26: Share of Mergers and Acquisitions (by Company), January 2020-March 2023
Figure 27: Share of Investments and Other Activities (by Company), January 2020-March 2023
Figure 28: Market Share Analysis for Global Functional Genomics Market, $Billion, 2022
Figure 29: Global Functional Genomics Market (by Product)
Figure 30: Share of Global Functional Genomics Market (by Product), $Billion, 2022 and 2033
Figure 31: Global Functional Genomics Market (Kits and Assays), ($Billion), 2022-2033
Figure 32: Global Functional Genomics Market (Instruments), ($Billion), 2022-2033
Figure 33: Global Functional Genomics Market (by Technology)
Figure 34: Share of Global Functional Genomics Market (by Technology), $Billion, 2022 and 2033
Figure 35: Global Functional Genomics Market (Next-Generation Sequencing (NGS)), $Billion, 2022-2033
Figure 36: Global Functional Genomics Market (Polymerase Chain Reaction (PCR)), $Billion, 2022-2033
Figure 37: Global Functional Genomics Market (Microarray), $Billion, 2022-2033
Figure 38: Global Functional Genomics Market (Other Technologies), $Billion, 2022-2033
Figure 39: Global Functional Genomics Market (by Application)
Figure 40: Global Functional Genomics Market (by Application), $Billion, 2022 and 2033
Figure 41: Global Functional Genomics Market (Epigenomics), $Billion, 2022-2033
Figure 42: Global Functional Genomics Market (Transcriptomics), $Billion, 2022-2033
Figure 43: Global Functional Genomics Market (Proteomics), $Billion, 2022-2033
Figure 44: Global Functional Genomics Market (Metabolomics), $Billion, 2022-2033
Figure 45: Global Functional Genomics Market (by End User)
Figure 46: Global Functional Genomics Market (by End User), $Billion, 2022 and 2033
Figure 47: Global Functional Genomics Market (Academic and Research Institutions), $Billion, 2022-2033
Figure 48: Global Functional Genomics Market (Biotechnology and Biopharmaceutical Companies), $Billion, 2022-2033
Figure 49: Global Functional Genomics Market (Other End Users), $Billion, 2022-2033
Figure 50: Global Functional Genomics Market Snapshot (by Region)
Figure 51: Global Functional Genomics Market (by Region), $Billion, 2023-2033
Figure 52: North America Functional Genomics Market, $Billion, 2023-2033
Figure 53: North America Functional Genomics Market (by Country), $Billion, 2023-2033
Figure 54: U.S. Functional Genomics Market, $Billion, 2022-2033
Figure 55: Canada Functional Genomics Market, $Billion, 2022-2033
Figure 56: Europe Functional Genomics Market, $Billion, 2022-2033
Figure 57: Europe Functional Genomics Market (by Country), $Billion, 2022-2033
Figure 58: Germany Functional Genomics Market, $Billion, 2022-2033
Figure 59: France Functional Genomics Market, $Billion, 2022-2033
Figure 60: U.K. Functional Genomics Market, $Billion, 2022-2033
Figure 61: Italy Functional Genomics Market, $Billion, 2022-2033
Figure 62: Spain Functional Genomics Market, $Billion, 2022-2033
Figure 63: Rest-of-Europe Functional Genomics Market, $Billion, 2022-2033
Figure 64: Asia-Pacific Functional Genomics Market, $Billion, 2022-2033
Figure 65: Asia-Pacific Functional Genomics Market (by Country), $Billion, 2022-2033
Figure 66: China Functional Genomics Market, $Billion, 2022-2033
Figure 67: Japan Functional Genomics Market, $Billion, 2022-2033
Figure 68: India Functional Genomics Market, $Billion, 2022-2033
Figure 69: Australia Functional Genomics Market, $Billion, 2022-2033
Figure 70: Singapore Functional Genomics Market, $Billion, 2022-2033
Figure 71: Rest-of-Asia-Pacific Functional Genomics Market, $Billion, 2022-2033
Figure 72: Latin America Functional Genomics Market, $Billion, 2022-2033
Figure 73: Latin America Functional Genomics Market Share (by Country), $Million, 2022-2033
Figure 74: Brazil Functional Genomics Market, $Million, 2022-2033
Figure 75: Mexico Functional Genomics Market, $Million, 2022-2033
Figure 76: Rest-of-Latin America Functional Genomics Market, $Million, 2022-2033
Figure 77: Rest-of-the-World Functional Genomics Market, $Billion, 2022-2033
Figure 78: Global Functional Genomics Market, Total Number of Key Companies Profiled
Figure 79: Agilent Technologies, Inc.: Product Portfolio
Figure 80: Agilent Technologies, Inc.: Overall Financials, $Million, 2020-2022
Figure 81: Agilent Technologies, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 82: Agilent Technologies, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 83: Agilent Technologies, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 84: Becton, Dickinson and Company (BD): Product Portfolio
Figure 85: Becton, Dickinson and Company (BD).: Overall Financials, $Million, 2020-2022
Figure 86: Becton, Dickinson and Company (BD).: Revenue (by Segment), $Million, 2020-2022
Figure 87: Becton, Dickinson and Company (BD).: Revenue (by Region), $Million, 2020-2022
Figure 88: Becton, Dickinson and Company (BD).: R&D Expenditure, $Million, 2020-2022
Figure 89: Bio-Rad Laboratories, Inc.: Product Portfolio
Figure 90: Bio-Rad Laboratories, Inc.: Overall Financials, $Million, 2020-2022
Figure 91: Bio-Rad Laboratories, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 92: Bio-Rad Laboratories, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 93: Bio-Rad Laboratories, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 94: Danaher. (Integrated DNA Technologies, Inc.): Product Portfolio
Figure 95: Danaher. (Integrated DNA Technologies, Inc.): Overall Financials, $Million, 2020-2022
Figure 96: Danaher. (Integrated DNA Technologies, Inc.): Revenue (by Segment), $Million, 2020-2022
Figure 97: Danaher. (Integrated DNA Technologies, Inc.): Revenue (by Region), $Million, 2020-2022
Figure 98: Danaher. (Integrated DNA Technologies, Inc.): R&D Expenditure, $Million, 2020-2022
Figure 99: Exact Sciences Corporation: Product Portfolio
Figure 100: Exact Sciences Corporation: Overall Financials, $Million, 2020-2022
Figure 101: Exact Sciences Corporation: Revenue (by Segment), $Million, 2020-2022
Figure 102: Exact Sciences Corporation: Revenue (by Region), $Million, 2020-2022
Figure 103: Exact Sciences Corporation: R&D Expenditure, $Million, 2020-2022
Figure 104: F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 105: F. Hoffmann-La Roche Ltd: Overall Financials, 2020-2022
Figure 106: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2020-2022
Figure 107: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2020-2022
Figure 108: Illumina, Inc.: Product Portfolio
Figure 109: Illumina, Inc.: Overall Financials, $Million, 2020-2022
Figure 110: Illumina, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 111: Illumina, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 112: Illumina, Inc. (GRAIL, LLC.): R&D Expenditure, $Million, 2020-2022
Figure 113: Merck KGaA: Product Portfolio
Figure 114: Merck KGaA: Overall Financials, $Million, 2020-2022
Figure 115: Merck KGaA: Revenue (by Segment), $Million, 2020-2022
Figure 116: Merck KGaA: Revenue (by Region), $Million, 2020-2022
Figure 117: Merck KGaA: R&D Expenditure, $Million, 2020-2022
Figure 118: MRM Proteomics: Product Portfolio
Figure 119: Pacific Biosciences of California, Inc: Product Portfolio
Figure 120: Pacific Biosciences of California, Inc.: Overall Financials, 2020-2022
Figure 121: Pacific Biosciences of California, Inc.: Revenue (by Segment), 2020-2022
Figure 122: Pacific Biosciences of California, Inc.: Revenue (by Region), 2020-2022
Figure 123: Pacific Biosciences of California, Inc.: R&D Expenditure, 2020-2022
Figure 124: Perkin Elmer, Inc.: Product Portfolio
Figure 125: PerkinElmer, Inc.: Overall Financials, $Million, 2020-2022
Figure 126: PerkinElmer, Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 127: PerkinElmer, Inc.: Revenue (by Region), $Million, 2020-2022
Figure 128: PerkinElmer, Inc.: R&D Expenditure, $Million, 2020-2022
Figure 129: Promega Corporation: Product Portfolio
Figure 130: QIAGEN.: Product Portfolio
Figure 131: QIAGEN: Overall Financials, $Million, 2019-2021
Figure 132: QIAGEN: Revenue (by Segment), $Million, 2019-2021
Figure 133: QIAGEN: Revenue (by Region), $Million, 2019-2021
Figure 134: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021
Figure 135: Thermo Fisher Scientific Inc.: Product Portfolio
Figure 136: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2020-2022
Figure 137: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2020-2022
Figure 138: Thermo Fisher Scientific Inc.: Revenue (by Region), $Million, 2020-2022
Figure 139: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2020-2022
List of Tables
Table 1: Global Functional Genomics Market: Impact Analysis
Table 2: Technological Trends in Global Functional Genomics Market
Table 3: Technological Advancements in the Functional Genomics Ecosystem
Table 4: Initiatives Taken by the Government in Functional Genomics
Table 5: Cancers and Their Most Common Biomarker Tests
Table 6: Kits and Assays Offered by Key Players
Table 7: Instruments Offered by Key Players
Table 8: Next-Generation Sequencing (NGS) Based Products for Functional Genomics
Table 9: Polymerase Chain Reaction (PCR) Based Products for Functional Genomics
Table 10: Microarray-Based Products for Functional Genomics
Table 11: North America: Market Dynamics
Table 12: Europe: Market Dynamics
Table 13: Asia-Pacific: Market Dynamics
Table 14: Latin America: Market Dynamics